ACMSD anticorps

N° du produit ABIN2856426

Détail du produit anti-ACMSD anticorps

Antigène: ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ACMSD est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain, Souris

Attributs du produit: Rabbit Polyclonal antibody to ACMSD (aminocarboxymuconate semialdehyde decarboxylase)
ACMSD antibody [N2C3]

Purification: Purified by antigen-affinity chromatography.

Immunogène: Recombinant protein encompassing a sequence within the center region of human ACMSD. The exact sequence is proprietary.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Commentaires:

Positive Control: Mouse brain

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.86 mg/mL

Buffer: 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Détails sur ACMSD

Antigène: ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))

Autre désignation: aminocarboxymuconate semialdehyde decarboxylase (ACMSD Produits)

Synonymes: anticorps zgc:162888, anticorps ACMSD, anticorps aminocarboxymuconate semialdehyde decarboxylase, anticorps aminocarboxymuconate semialdehyde decarboxylase S homeolog, anticorps amino carboxymuconate semialdehyde decarboxylase, anticorps ACMSD, anticorps acmsd, anticorps acmsd.S, anticorps Acmsd

Sujet: The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase, EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.[supplied by OMIM]

Poids moléculaire: 38 kDa

ID gène: 130013

UniProt: Q8TDX5